Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Serum mucosa-associated epithelial chemokine in atopic dermatitis : A specific marker for severity
Indian Journal of Dermatology, 09/16/09
Ezzat MHM et al. – The authors data reinforce the concept that CCL28 might share in the pathogenesis of AD probably through selective migration and infiltration of effector/memory Th2 cells into the skin. It may also represent an objective prognostic marker for disease severity. Further studies may pave the way for CCL28 antagonism among the adjuvant therapeutic strategies.
Related Articles
Topical tacrolimus as treatment of atopic dermatitis
Clinical, Cosmetic and Investigational Dermatology, 11/11/09
Relevance Score: 67%
Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09
Relevance Score: 67%
Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis
Pediatric Allergy and Immunology, 10/15/09
Relevance Score: 67%
Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis
Allergy, 10/13/09
Relevance Score: 67%
Structured education program improves the coping with atopic dermatitis in children and their parents--a multicenter, randomized controlled trial
Journal of Psychosomatic Research, 10/09/09
Relevance Score: 67%
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial
Allergy, 12/17/09
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


